Mitchell Terk

693 total citations
16 papers, 486 citations indexed

About

Mitchell Terk is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Mitchell Terk has authored 16 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Surgery. Recurrent topics in Mitchell Terk's work include Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (8 papers) and Cancer survivorship and care (2 papers). Mitchell Terk is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (8 papers) and Cancer survivorship and care (2 papers). Mitchell Terk collaborates with scholars based in United States, Netherlands and Belgium. Mitchell Terk's co-authors include Nelson N. Stone, Richard G. Stock, Jamie A. Cesaretti, J. Keith DeWyngaert, Peter Dottino, Sejal M. Barden, Barry S. Rosenstein, Sarah L. Kerns, Harry Ostrer and Dirk De Ruysscher and has published in prestigious journals such as The Journal of Urology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Mitchell Terk

16 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell Terk United States 9 318 121 120 88 78 16 486
Lydia T Madsen United States 14 459 1.4× 57 0.5× 40 0.3× 30 0.3× 164 2.1× 30 733
Naji J. Touma Canada 11 377 1.2× 47 0.4× 53 0.4× 79 0.9× 140 1.8× 43 560
Alfonso Mariño Spain 11 389 1.2× 99 0.8× 51 0.4× 59 0.7× 171 2.2× 18 609
Anjali Zarkar United Kingdom 9 202 0.6× 100 0.8× 35 0.3× 66 0.8× 87 1.1× 26 319
Marketa Skala Australia 13 278 0.9× 158 1.3× 27 0.2× 96 1.1× 62 0.8× 23 392
Carmen Maccagnano Italy 17 504 1.6× 13 0.1× 117 1.0× 51 0.6× 221 2.8× 31 816
Gagan Prakash India 14 399 1.3× 173 1.4× 103 0.9× 66 0.8× 353 4.5× 97 739
Abhinav Dewan India 10 94 0.3× 87 0.7× 40 0.3× 75 0.9× 123 1.6× 40 284
Alfred H. Brandon United States 10 237 0.7× 23 0.2× 41 0.3× 52 0.6× 147 1.9× 15 410
Damiano Vizziello Italy 9 411 1.3× 49 0.4× 22 0.2× 64 0.7× 75 1.0× 22 566

Countries citing papers authored by Mitchell Terk

Since Specialization
Citations

This map shows the geographic impact of Mitchell Terk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Terk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Terk more than expected).

Fields of papers citing papers by Mitchell Terk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Terk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Terk. The network helps show where Mitchell Terk may publish in the future.

Co-authorship network of co-authors of Mitchell Terk

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Terk. A scholar is included among the top collaborators of Mitchell Terk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Terk. Mitchell Terk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Smith, William H., Jamie A. Cesaretti, Mitchell Terk, et al.. (2023). Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancer. Urologic Oncology Seminars and Original Investigations. 41(6). 296.e9–296.e16. 1 indexed citations
2.
Smith, William H., et al.. (2020). Salvage low dose rate brachytherapy for prostate cancer recurrence following definitive external beam radiation therapy. Radiotherapy and Oncology. 155. 42–47. 10 indexed citations
3.
Vargas, Carlos, Mitchell Terk, Joshua R. Niska, et al.. (2019). Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancer. Cancer Treatment and Research Communications. 19. 100119–100119. 2 indexed citations
4.
Barden, Sejal M., et al.. (2018). Prostate cancer: the influence of stigma on quality of life and relationship satisfaction for survivors and their partners. Journal of Psychosocial Oncology. 37(3). 350–366. 17 indexed citations
5.
Barden, Sejal M., et al.. (2017). The influence of stigma on the quality of life for prostate cancer survivors. Journal of Psychosocial Oncology. 35(4). 451–467. 15 indexed citations
6.
Kerns, Sarah L., Richard G. Stock, Nelson N. Stone, et al.. (2013). Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. Radiotherapy and Oncology. 107(3). 372–376. 57 indexed citations
7.
Kerns, Sarah L., Richard G. Stock, Nelson N. Stone, et al.. (2012). A 2-Stage Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms Associated With Development of Erectile Dysfunction Following Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 85(1). e21–e28. 52 indexed citations
8.
Vargas, Carlos, et al.. (2012). Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy. Brachytherapy. 12(2). 120–125. 6 indexed citations
9.
Terk, Mitchell, et al.. (2010). 1747 BRACHYTHERAPY FOR LOCALIZED PROSTATE CANCER: OUTCOME RESULTS WITH 10 YEARS MINIMUM FOLLOW-UP. The Journal of Urology. 183(4S). 3 indexed citations
10.
Terk, Mitchell. (2007). Brachytherapy for prostate cancer. Community Oncology. 4(2). 89–92. 2 indexed citations
11.
Presser, Joseph, et al.. (2001). Multicenter experience with prostate brachytherapy training. International Journal of Radiation Oncology*Biology*Physics. 51(3). 199–200. 1 indexed citations
12.
Terk, Mitchell, Richard G. Stock, & Nelson N. Stone. (1998). IDENTIFICATION OF PATIENTS AT INCREASED RISK FOR PROLONGED URINARY RETENTION FOLLOWING RADIOACTIVE SEED IMPLANTATION OF THE PROSTATE. The Journal of Urology. 1379–1382. 10 indexed citations
13.
Terk, Mitchell, Richard G. Stock, & Nelson N. Stone. (1998). IDENTIFICATION OF PATIENTS AT INCREASED RISK FOR PROLONGED URINARY RETENTION FOLLOWING RADIOACTIVE SEED IMPLANTATION OF THE PROSTATE. The Journal of Urology. 160(4). 1379–1382. 211 indexed citations
14.
Terk, Mitchell, et al.. (1997). A new technique for performing syed-neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance. International Journal of Radiation Oncology*Biology*Physics. 37(4). 819–825. 61 indexed citations
15.
Stock, Richard G., Peter Dottino, Mitchell Terk, et al.. (1997). Enhanced Radiosensitization with Interferon-α-2b and Cisplatin in the Treatment of Locally Advanced Cervical Carcinoma. Gynecologic Oncology. 67(3). 309–315. 7 indexed citations
16.
Lehrer, Steven, et al.. (1996). Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer. British Journal of Cancer. 74(6). 871–873. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026